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A B S T R A C T
This is the protocol for a review and there is no abstract. The objectives are as follows:
To determine whether interventions delivered by mobile phone can improve contraception use
B A C K G R O U N D
The rapid expansion in use of mobile phones in recent years has
had a dramatic impact on interpersonal communication. Within
the health domain, phone calls, text messages and smartphone
applications offer new means of communication between service
providers and clients. This review focuses on interventions deliv-
ered by mobile phone to improve contraception use.
Description of the condition
Contraception - methods or devices to prevent pregnancy - has
significant benefits for women’s and child health. The use of con-
traception prevents unintended pregnancies, reduces the number
of abortions and maternal deaths, and can improve perinatal out-
comes and child survival by widening the interval between succes-
sive pregnancies (Cleland 2012). There are also substantial social
and economic benefits of contraception such as improved educa-
tional and employment opportunities for women leading to in-
creasing family savings and economic growth (Singh 2009).
Despite these benefits, there is significant unmet need for contra-
ception. Unmet need refers to women not using a modern con-
traceptive method despite not wanting to have a child in the next
two years, or have no more children. An estimated 222 million
women of childbearing age in 2012 had unmet need for contra-
ception (Singh 2012). Unmet need for contraception can be due
to non-uptake or non-adherence to contraception. Themost com-
mon reasons for non-use are health concerns, including fear and
experience of side effects. (Ali 2010; Bradley 2009;Westoff 2012).
If unmet need for modern methods of contraception were met
amongst women in developing countries, this would prevent an
additional 54 million unintended pregnancies, 26 million abor-
tions (of which half would be unsafe), 79,000 maternal deaths and
1.1 million infant deaths (Singh 2012).
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Description of the intervention
In the last decade there has been a rapid expansion in the delivery of
health care interventions via mobile phone (Mechael 2010). Inter-
ventions delivered bymobile phone have been designed to improve
health outcomes for individual clients for acute and chronic disease
management and for health promotion. These include interven-
tions designed to improvemedication adherence, appointment at-
tendance or promote behaviour change (Free 2013a; Free 2013b;
Whittaker 2009). Interventions delivered by mobile phone have
also provided anovelmeans for deliveringpatient tests (Bastawrous
2012).
Interventions can utilise different functions of mobile phones for
example, text message, voice message, video and application. They
may involve one-direction or two-way (interactive) communica-
tion (Free 2010; Kallander 2013). Interventions could employ sin-
gle functions or combined functions of mobile phones such as
interactive text message based support, or voice messaging com-
bined with telephone counselling. Interventions delivered by mo-
bile phone to improve contraception use could be delivered as an
adjunct or alternative to face-to-face services. Interventions could
aim to increase uptake of contraception amongst non-users. In-
terventions for existing contraceptive users could aim to increase
adherence to contraception, reduce discontinuation of contracep-
tives and/or encourage swapping contraceptives rather than stop-
ping contraceptives if side effects are experienced.
How the intervention might work
Interventions delivered by mobile phone have potential advan-
tages over face-to-face healthcare delivery as support can be de-
livered wherever the person is located, and whenever it is needed
(Rodgers 2005). Such interventions could be popular with youth
populationswho are regularmobile phone users (Whittaker 2009).
Furthermore, these interventions have the potential to reach ru-
ral populations, where geographical distances can restrict access to
services (Car 2012).
Intervention content could include information, pill or appoint-
ment reminders and/or content designed to increase or maintain
motivation to use contraception. Behaviour change techniques
used in face-to-face interventions can be modified for delivery by
mobile phone (Free 2013a). Interventions could utilise a range
of behaviour change techniques, such as encouraging women to
make a clear plan about when, where and how they will use con-
traception (goal setting) (Abraham 2008). Multi-faceted interven-
tions that address a wide range of barriers to contraception use
could be more effective that those targeting single barriers to use.
Existing adherence research suggests that multifaceted interven-
tions can be effective but uni-faceted interventions have at best
modest benefits (Haynes 2008). Similarly, there is no evidence
that medication reminders delivered by mobile phone have ben-
efits (pooled risk ratio 1.00, 95% confidence interval 0.77-1.30)
(Free 2013a), whilst trials of more complex interventions to in-
crease adherence to antiretroviral medication report benefits (Free
2013a; Lester 2010).
There are several potential risks of using mobile phones to im-
prove contraception use. Road traffic accidents are the only ad-
verse health effect of cell phone use for which there is evidence
(Rothman 2000). However, in the often sensitive context of con-
traception, there is potential for physical or psychological adverse
effects that could arise as a result of other people accessing inter-
vention content when mobile phones are shared. A further risk
relates to the opportunity cost of investing substantial resources
in developing a technologically focused intervention with most
likely a moderate impact instead of investing in alternative ap-
proaches. Additional challenges relating to the implementation of
interventions delivered by mobile phone include reduced literacy
of target populations, incomplete network coverage, phone num-
ber switching, and the risk of incomplete data input and this in-
accurate data being acted upon (Bullen 2013; Upadhyay 2009).
Why it is important to do this review
Interventions delivered by mobile phone have been demonstrated
to be effective in other areas such as smoking cessation (Free 2011;
Horvath 2012; Whittaker 2009). Where interventions delivered
by mobile phone have been shown to be effective they have also
been shown to be highly cost effective (Guerriero 2013). However,
there is more limited evidence related to interventions delivered
by mobile phone for contraception.
In recent years there has been growing interest in interventions de-
livered by mobile phone, reflected in a number of mobile phone-
based contraception initiatives that have been launched, and in
some cases scaled up, for example, Mobile Technology for Im-
proved Family Planning (MOTIF), mAssist, Mobile for Repro-
ductive Health (m4RH), CycleTel, Mobile Alliance for Mater-
nal Action (MAMA); each with different approaches to the inter-
vention and evaluation (Constant 2010; CycleTel 2011; L’engle
2013;MAMA 2013; Smith 2013). Although these initiatives look
promising, to date, the effect of interventions delivered by mo-
bile phone on contraception have not been reliably established.
Therefore a review of interventions delivered by mobile phone for
contraception is timely.
O B J E C T I V E S
To determine whether interventions delivered by mobile phone
can improve contraception use
M E T H O D S
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Criteria for considering studies for this review
Types of studies
Randomised controlled trials (RCTs).
Types of participants
Eligible participants will be men or women of reproductive age
who are users or potential users of contraceptive methods. We will
include studies in all settings, i.e. primary care settings, outpatient
settings, community settings and hospital settings. We will not
exclude studies according to the type of healthcare provider (e.g.
doctor, nurse, allied staff ).
Types of interventions
We will include studies which examine any type of client-provider
intervention delivered by mobile phone designed to improve use
of contraception compared to standard delivery of care or another
intervention. We will include interventions directed at both users
and non-users of contraception. We will include interventions
designed to:
• Improve uptake of contraception (including post-abortion
and post-partum contraception)
• Promote specific methods of contraception
• Improve adherence to contraception e.g. interventions to
support clients’ experiencing side-effects, reduce discontinuation,
safe method switching, pill or appointment reminders
We will include any intervention aimed at mobile phone users
delivered by mobile phone, for example, text message, voice mes-
sage and applications. We will exclude trials where mobile phones
were used for two-way voice communication (as a phone) alone.
Web-based interventions can be accessed on mobile phones as well
as other platforms, but in practice can be difficult to access via
mobile phone unless they are adapted for mobile phone use. We
will exclude web-based interventions unless the paper states they
have been intended for or adapted for mobile phone users. We will
exclude trials that only focus on preventing sexually transmitted
diseases rather than contraception.
Types of outcome measures
Contraceptive methods can be classified in different ways. Contra-
ception can be classed as either modern (e.g. condom, oral contra-
ceptive pills, injectables, intra-uterine device, implant, emergency
contraception) or traditional (e.g. rhythm/periodic abstinence or
withdrawal) (Westoff 2012; WHO 2013). Furthermore, distinc-
tions can be made between hormonal or non-hormonal meth-
ods, and short and long-acting or permanent methods. TheWorld
Health Organization classifies methods according to effectiveness,
according to estimated rates of unintended pregnancies per 100
women per year (WHO 2011). For this review we define effec-
tive modern methods as those associated with <10% 12-month
pregnancy rates, as commonly used: oral contraceptive, injectable,
implant, intra-uterine device, or permanent methods.
We will include studies which include any form of contraceptive
use.We will include studies assessing a range of outcome measures
related to contraceptive use including uptake of contraception,
selection of a specific method, measures of adherence (including
discontinuation and safe-switching), pregnancy or abortion.
Both sustained and point prevalence measures will be considered.
Both subjective (self-reported) and objective (e.g. biochemically
verified, use of electronic medication monitors, clinical examina-
tion) assessment of contraception use will be considered.
Primary outcomes
• Uptake of contraception (including post-abortion and post-
partum contraception)
• Uptake of a specific method of contraception (e.g. a long-
acting method)
• Adherence to contraceptive method (e.g. number of missed
pills, attendance for repeat injection)
• Safe-method switching (e.g. from one effective method to
another with no gap)
• Discontinuation of contraception
• Pregnancy or abortion (objectively measured or self-
reported)
Secondary outcomes
• Road traffic accidents - the only adverse health effect of cell
phone use for which there is evidence (Rothman 2000).
• Any physical or psychological effect reported
Search methods for identification of studies
Electronic searches
We will search the following electronic databases:
• Cochrane Central Register of Controlled Trials
(CENTRAL)
• MEDLINE using OVID
• EMBASE using OVID
• Global Health using OVID
• Psyc INFO using OVID
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• POPLINE
• Africa-Wide Information
• LILACS
We will include Africa-Wide Information and LILACS given the
proliferationofmobile phone-based initiatives in low- andmiddle-
income regions. We will search for recent clinical trials separately
via the following databases: clinical trials registry at the WHO
International Clinical Trials Registry Platform (www.who.int/tri-
alsearch), “ClinicalTrials.gov”, the search portal of the Interna-
tional Clinical Trials Registry Platform (ICTRP), and Current
Controlled Trials (www.controlled-trials.com).
We will search for studies published in all languages since January
1993 until present as the first text message was sent in December
1992 (Kellon 2012). The strategy for MEDLINE (Ovid) is pre-
sented in Appendix 1 and will be adapted to the above databases.
If additional key words of relevance are identified during any of
the searches, electronic search strategies will be modified to in-
corporate these terms in agreement with the Cochrane review co-
ordinating editor.
Searching other resources
We will write to the contact investigators of identified and in-
cluded studies to request additional information about the study
where appropriate, as well as information about trials not dis-
covered in our search. We will review abstracts of key confer-
ences (mHealth summit, Women Deliver, International Confer-
ence on Family Planning) and also review of online repositories
of mHealth interventions (Health unbound, Royal Tropical Insti-
tute: mHealthinfo, K4Health: mHealth evidence)
Data collection and analysis
Selection of studies
Search results will be exported into a bibliographic citation man-
agement software programme and duplicate references excluded.
Titles and abstracts of studies retrieved using the search strategy
will be screened independently by two review authors. Full articles
will be retrieved for further assessment if the information given
suggests that the study (1) includes participants who are users or
potential users of contraception (2) compares the use of an inter-
vention delivered by mobile phone with routine standard of care
or another intervention, (3) assesses one or more relevant outcome
measure.
If there is any doubt regarding these criteria from the information
in the title and abstract, the full article will be retrieved for clarifi-
cation. The full text of potentially eligible studies will be retrieved
and independently assessed for eligibility by two review authors,
with any disagreement resolved through discussion with a third
author.
Data extraction and management
Two authors will independently extract the following data from
the included studies using a standardised data extraction form:
(1)General information: title, authors, complete citation, publica-
tion status, date published, language, review author information,
date reviewed, sponsoring, setting
(2) Study characteristics: study design, aim of study, duration,
participant recruitment, sampling, inclusion/exclusion criteria in-
cluding numbers screened and eligible, randomisation, allocation
concealment, method of allocation concealment, blinding, in-
formed consent, was a power analysis performed?
(3) Risk of bias: additional data will be collected depending on
the study design (see Assessment of risk of bias in included
studies )
(4) Participants: description, geographic location, setting, number,
age, ethnicity, socioeconomic status distribution
(5) Providers: description, geographic location, setting
(6) Intervention: description, aim of intervention, any behaviour
change intervention (according to the study authors description
and our assessment according to an established typology of be-
haviour change techniques (Abraham 2008)), duration, frequency
/ dose , control/placebo intervention, technical specifications
including device and mobile phone functions used (e.g. text mes-
sage, voice message), message content, co-interventions
(7) Outcomes: outcomes as specified above, other outcomes as-
sessed, length of follow-up, methods of assessing outcomes, com-
pleteness of outcome data, follow up for non-respondents, adverse
events
(8) Results: for outcomes and times of assessment, intention to
treat analysis (where all randomised participants are included ir-
respective of what happened subsequently (Newell 1992)).
Any disagreements will be discussed by the authors with any dis-
agreement resolved through discussion with a third author as nec-
essary.
Assessment of risk of bias in included studies
Studies will be assessed for risk of bias in accordance with the
Cochrane Handbook for Systematic Reviews of Interventions
(Higgins 2011) across the following domains: sequence genera-
tion, allocation concealment, blinding, incomplete outcome data,
selective outcome reporting and other potential biases. Two review
authors will independently assess the risk of bias with any disagree-
ment discussed by the authors and resolved through discussion
with a third author as necessary. We will use a standardised form
to guide the assessment of risk of bias, and will judge each domain
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as high , low or unclear . All included studies will be
presented by study type and risk of bias level. As required, we will
contact study authors for additional information. The results of
the risk of bias assessment will be presented in tables, and as a
systematic narrative description.
Measures of treatment effect
We will use risk ratios (RR) as measure of treatment effect for di-
chotomous outcomes and mean differences (MD) for continuous
outcomes. We will report confidence intervals with all measures
of effect.
Unit of analysis issues
We will take into account unit of analysis issues resulting from
cluster RCTs, repeated measurements, and studies with more than
one treatment group. If appropriate, data will be analysed in ac-
cordance with the Cochrane handbook (Higgins 2011).
Dealing with missing data
Missing data on individuals will be assessed as guided by the
Cochrane handbook. We will ignore the missing data if it is as-
sumed to be missing at random. If feasible, we will contact study
authors for missing data where it is assumed to be not missing
at random, for example if some randomised participants were ex-
cluded from analyses. If feasible, we will use statistical techniques,
as appropriate to each study, to impute the missing data in order
to enable an available case or intention-to-treat analysis. (Higgins
2011) For missing summary data, if feasible, we will approximate
the correct analyses to impute missing summary statistics, e.g.
standard deviations, in accordance with the Cochrane handbook
(Higgins 2011).
Assessment of heterogeneity
We anticipate that there will be limited scope formeta-analysis due
to differences in interventions and outcome measures. However,
if sufficient studies are identified, we will examine heterogeneity
between the trials using the I2 statistic, with an I2 estimate greater
than 50% indicating a substantial level of heterogeneity (Higgins
2011).
In the result of substantial clinical, methodological or statistic
heterogeneity, study resultswill not be combined in ameta-analysis
and we will attempt to determine reasons for this by examining
individual study characteristics.
Assessment of reporting biases
If we identify studies with similar interventions and outcomemea-
sures, we will assess reporting biases statistically and using funnel
plots in RevMan 5. We will minimise the potential for reporting
bias by using comprehensive search strategies.
Data synthesis
We will conduct statistical analysis according to the guidelines in
the Cochrane handbook (Higgins 2011). We will present a narra-
tive overview of the findings together with tabular summaries of
extracted data. If study populations, interventions, comparators
and outcomes are sufficiently similar, we will pool the data across
studies and estimate summary effect sizes. We will use theMantel-
Haenszel risk ratio fixed effects method for dichotomous data and
the MD for continuous data. Where meta-analysis is not possible,
we will present summary and descriptive statistics. We will sum-
marise the quality of evidence provided by the studies using the
GRADE approach (Higgins 2011).
Subgroup analysis and investigation of heterogeneity
Although we predict number of studies to be low as in previ-
ous reviews of mobile phone-based interventions (Horvath 2012;
Whittaker 2009), if one of the primary outcome parameters
demonstrates statistically significant differences (at p<0.01) be-
tween treatment groups we will perform subgroup and sensitivity
analyses. These would include meta-analyses on studies amongst
specific populations, specifically; younger vs. older women; high
income vs low income settings; post-delivery vs post abortion vs
general clinic attendees.
It is not anticipated that many studies will be identified that pro-
mote traditional contraceptive methods, as family planning pro-
grammes and trials are more likely to promote modern, more ef-
fective methods. However, if such studies are identified, we will
consider undertaking a sub-group analysis only including mod-
ern methods or those considered effective or very effective by the
WHO (WHO 2011).
Sensitivity analysis
It is not anticipated that we will identify a large number of studies.
However, if appropriate, we will perform sensitivity analysis in
order to explore the influence of the following factors on effect
size:
• repeating the analysis excluding unpublished studies
• repeating the analysis taking account of risk of bias of
included studies, as specified above
A C K N OW L E D G E M E N T S
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A P P E N D I C E S
Appendix 1. MEDLINE (Ovid) search strategy
Intervention delivered by mobile phone
((phone adj3 call*) OR ((cell* or mobile or smart or google or nexus or iphone) adj3 (phone* or telephone*)) OR (smartphone*)
OR (smart-phone*) OR (blackberr* NOT extract) OR (black-berr* NOT extract)) OR ((mobile adj3 (health NOT (van* or unit*)))
OR (mhealth) OR (m-health) OR (e-health*) OR (ehealth*) OR (electronic adj health) OR (mobile adj3 technol*)) OR ((mobile or
smartphone or smart-phone or phone or software) adj3 (app*)) OR ((MMS) OR (multimedia messaging service) OR (SMS)OR (short
messag* service) OR (text* adj messag*) OR (text-messa*) OR (voice messag*) OR (interactive voice response) OR (IVR)) OR MeSH
‘Telemedicine’ (not exp.) OR MeSH ‘Cellular phone’ (exp to include text messaging)
AND
contraception
((contracept*) OR (family adj planning) OR (Birth adj control)) OR (condom) OR ((OC adj pill)) OR ((depot medroxyprogest*) OR
(NET-EN) OR (NET EN) OR (Mesigyna) OR (Cyclofem)) OR ((NORPLANT) OR (implanon) OR (Femplant)) OR ((intrauterine
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system) OR (intra-uterine system) OR (IUS) OR (intrauterine device) OR (intra-uterine device) OR (IUD)) OR ((vasectomy) OR
(sterilisation) OR (sterilization) OR (tubal adj ligation)) OR ((vaginal adj ring) OR (cycletel) OR (cycle-tel) or (abstain) OR (abstinen*)
OR (lactational amenorr*)) OR ((pregnan*) OR (abortion)) OR MeSH: Contraception (exp.) OR MeSH: contraceptive devices
(includes condom) ORMeSH exp Pregnancy, Unplanned/ ORMeSH exp Pregnancy, Unwanted/ OR MeSH exp Abortion, Induced/
Limits Activated: After 1993, Clinical Trial
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